Two older adults may have similar muscle strength, yet move very differently. One rises from a chair and walks off confidently. The other pauses to steady themselves and struggles to recover from a small stumble.
The difference may lie partly in how well the brain, nerves, and muscles work together. A new proposal suggests that this broader system deserves more attention when doctors assess declining strength and mobility in older adults.
In a paper published in The Lancet Healthy Longevity, researchers propose reframing sarcopenia—a condition involving declining muscle strength and muscle mass, commonly associated with aging—as a disease of the aging motor system.
Their argument has a practical implication: Helping someone remain independent may require looking beyond how much muscle they have to understand how effectively they can use it.
Why Muscles Are Only Part of the Picture
Sarcopenia once simply meant age-related muscle loss. Definitions have since shifted to emphasize strength and physical performance, but the condition is still largely treated as a muscle problem.
That view is incomplete, Lucas Orssatto, of the Centre for Sensorimotor Performance at the University of Queensland and corresponding author of the article, told The Epoch Times. “The trouble is that muscle loss explains only a modest part of the strength people lose with age.”
Muscles don’t work alone. They depend on a chain called the motor system: The brain plans the movement, the spinal cord and nerves carry and amplify signals, and those signals cross the junctions where nerves meet muscles, triggering contraction. Sensors in the muscles also tell the brain where the limbs are.
“Aging affects every link of this system,” Orssatto said.
With age, some of the nerve cells that control muscles die, surviving nerves take over more muscle fiber, signals travel less efficiently, and communication between nerves and muscles becomes less reliable. Sensory feedback that helps with position and balance also becomes less precise.
Sarcopenia is like a lamp that will not turn on, he said. The bulb (the muscle) might be at fault, but so might the switch (the brain), the wiring (the spinal cord and nerves), or the socket (where nerve meets muscle).
“A new bulb won’t help if the problem is in the wiring.”
“Sarcopenia is less about how much muscle someone has and more about how well their whole motor system works together to produce movement,” Mary Grace Doroteo, a physical therapist and vice chair of the American Physical Therapy Association Geriatrics Balance and Falls Special Interest Group, told The Epoch Times.
Why Muscle Building Treatments May Fall Short
The researchers say the muscle-only view shapes which treatments get developed and what clinicians look for when someone struggles to move.
In a randomized trial involving 180 adults aged 70 and older with sarcopenia, the drug bimagrumab increased lean body mass but did not improve physical function significantly more than placebo. Both groups received nutritional support and a home exercise program, and both improved their physical function.
One possible explanation is that they addressed only one part of the motor system while other problems went untreated. More muscle alone may not resolve problems elsewhere in the system that controls movement.
Researchers do not yet know how often treatment misses the main problem, Orssatto said, because current tests are not designed to identify it. “Several links are usually affected at once, so I would say treatment is more often incomplete than simply wrong.”
How Testing Would Change
Currently, doctors test for sarcopenia in three ways: by measuring grip strength with a handheld gauge, timing a short walk, and timing how long it takes someone to stand up from a chair five times without using their arms. A scan to estimate muscle mass is sometimes added.
These tests show that something is wrong, but not what. “They tell us a problem exists, but not why,” Doroteo said.
Walking speed, one of the best warning signs in older age, is an all-in-one measure, Orssatto said. It reflects muscles, balance, sensation, pain, motor control, and thinking at the same time.
The framework keeps these tests and proposes a two-stage approach. In routine care, doctors would keep the whole motor system in view—assessing reflexes, sensation, coordination, and the way a person walks.
The second stage is more detailed testing of the brain, nerves, and muscles in specialist clinics and research. Examples include electromyography to record muscle electrical activity, nerve conduction tests to assess how well nerves carry signals, and brain and muscle imaging. These could help identify what is limiting movement and guide treatment.
The framework also suggests adding three measures of different movement skills. “Each draws on a different mix of brain, nerve and muscle function, and together they make up the full report card,” Orssatto said.
Power: Rising From a Chair
Doctors already time chair stands, but the proposal would also look at how quickly someone stands. Strength is how much force someone can produce; power is how fast they can produce it, which depends partly on how quickly the nervous system activates the muscles.
Rising from a low chair requires power. Power tends to decline earlier and faster with age than strength or muscle mass, Orssatto said, and is more closely linked to everyday disability.
Ageing particularly affects fast-twitch muscle fibers used for quick, powerful movements and can reduce how rapidly the nervous system activates muscles, leaving less ability to generate force at speed.
Balance and Direction Changes: The 4-Square Step Test
For this test, the person steps forward, sideways, and backward over four sticks arranged in a cross, following a set sequence as quickly as possible.
The test assesses balance, quick stepping, and the ability to change direction while remembering the order of steps, Orssatto said.
Attention: Walking While Thinking
Walking while doing a mental task, such as counting backward by threes, can show how much attention walking requires. It can reveal problems that plain walking hides.
“An everyday parallel is the ‘stops walking when talking’ sign. People who stop walking when a conversation begins are more likely to have a fall soon,” Orssatto said, though continuing to walk does not rule out that risk. The same “dual-tasking” approach can be added to stepping or chair-rise tests, Orssatto said.
Many of the suggested movement tests are already quick and inexpensive and can be administered by doctors, physical therapists or other trained health professionals. What remains uncertain is how well using them together can identify the main sources of difficulty in sarcopenia and guide treatment, Orssatto said.
Check the Medicine Cabinet
Alongside assessing the motor system, the framework recommends reviewing medicines. Some sleeping pills and anti-anxiety drugs cause sedation, while certain allergy medicines, bladder medicines and older antidepressants block a chemical messenger that helps nerves communicate. Both can reduce physical capacity, Orssatto said. These effects can add up when several are taken together.
People should not stop medicines on their own, he said, as some need to be reduced gradually. “Ask your doctor or pharmacist for a review, and bring everything you take, including over-the-counter products and supplements.”
How the Shift Affects Treatment
Treatment for sarcopenia generally centers on exercise, particularly strength training, often alongside advice to eat enough protein. That would not change.
“Strength training works because it trains muscles and nerves together, so please keep exercising,” Orssatto said.
What the framework could change is how precisely clinicians identify what limits each person’s movement and tailor treatment accordingly, including more specific exercise plans.
“Strengthening alone often isn’t enough,” Doroteo said. “Adding power, balance, reactive stepping, and task-specific training lets us target what’s actually limiting the person’s function.”



